• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体重指数影响成年男性的抗苗勒管激素和抑制素B。

Body mass index influences Antimüllerian Hormone and inhibin B in adult males.

作者信息

Zhou Wen, Zhou Huanqun

机构信息

Department of Reproductive Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.

出版信息

Front Endocrinol (Lausanne). 2025 May 20;16:1547267. doi: 10.3389/fendo.2025.1547267. eCollection 2025.

DOI:10.3389/fendo.2025.1547267
PMID:40463744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12129801/
Abstract

BACKGROUND

The interplay between obesity and male reproductive health, particularly concerning reproductive hormone fluctuations, is a well-documented concern. Despite varied findings on the BMI-AMH/INHB relationship, this study utilized NHANES data (1999-2004) to clarify this association, aiming to refine the assessment of obesity's effects on the reproductive hormone levels of adult male Americans.

METHODS

We conducted a cross-sectional analysis involving 728 men aged 20 and older. Height and weight were measured by trained staff, and hormone levels were determined using the ELISA method. We performed weighted multiple linear regression to assess the associations between BMI and AMH/INHB, including subgroup interactions, and utilized smoothing curve fitting to analyze nonlinear relationships, along with a threshold effect analysis to evaluate key thresholds.

RESULTS

Participants in higher BMI quartiles showed a declining trend in AMH levels (P=0.16) and a significant reduction in INHB levels (P<0.01). A negative correlation between BMI and AMH (β: -0.15, 95%CI: -0.23 to -0.06, P<0.01) and INHB levels (β: -2.14, 95%CI: -2.98 to -1.31, <0.0001) was observed, with these correlations remaining statistically significant (AMH: β: -0.12, 95%CI: -0.23 to -0.01, <0.05; INHB: β: -1.50, 95%CI: -2.66 to -0.34, <0.05) after adjusting for relevant confounders. However, the effect size for AMH was relatively low, which may limit its clinical significance. In the fully adjusted model, the increase in BMI in Q4 was linked to decreases of 1.62 ng ml-1 in AMH and 18.20 pg ml in INHB, but these associations were not statistically significant (P>0.05). The association between BMI and AMH/INHB showed no significant interaction effects across all covariates (P>0.05 for the interaction), although negative correlations were present in most subgroups (P<0.05). While both AMH and INHB declined with increasing BMI, they displayed nonlinear relationship at key thresholds of 30.78 kg m-² (below: β=0.02, P>0.05; above: β=-0.30, P<0.05) and 33.86 kg m² (below: β=-1.24, P=0.05; above: β=-3.22, P<0.05).

CONCLUSIONS

BMI is associated with a relatively independent negative correlation with serum AMH and INHB levels in adult men, which is more noticeable in obese men and shows no significant interaction with other confounding factors. However, due to the low effect size of BMI/AMH, caution is needed in interpreting its clinical significance. Although we found a non-linear relationship and key thresholds between these variables, further studies with larger sample sizes are needed to confirm these findings.

摘要

背景

肥胖与男性生殖健康之间的相互作用,尤其是关于生殖激素波动的问题,是一个有充分文献记载的关注点。尽管关于体重指数(BMI)与抗缪勒管激素(AMH)/抑制素B(INHB)关系的研究结果各异,但本研究利用美国国家健康与营养检查调查(NHANES,1999 - 2004年)数据来阐明这种关联,旨在完善对肥胖对成年美国男性生殖激素水平影响的评估。

方法

我们对728名20岁及以上男性进行了横断面分析。由经过培训的工作人员测量身高和体重,并采用酶联免疫吸附测定(ELISA)法测定激素水平。我们进行加权多元线性回归以评估BMI与AMH/INHB之间的关联,包括亚组间相互作用,并利用平滑曲线拟合分析非线性关系,同时进行阈值效应分析以评估关键阈值。

结果

处于较高BMI四分位数的参与者,其AMH水平呈下降趋势(P = 0.16),INHB水平显著降低(P < 0.01)。观察到BMI与AMH(β: - 0.15,95%置信区间: - 0.23至 - 0.06,P < 0.01)以及INHB水平(β: - 2.14,95%置信区间: - 2.98至 - 1.31,P < 0.0001)之间存在负相关,在调整相关混杂因素后,这些相关性仍具有统计学意义(AMH:β: - 0.12,95%置信区间: - 0.23至 - 0.01,P < 0.05;INHB:β: - 1.50,95%置信区间: - 2.66至 - 0.34,P < 0.05)。然而,AMH的效应量相对较低,这可能限制了其临床意义。在完全调整模型中,第四四分位数中BMI的增加与AMH降低1.62 ng/ml和INHB降低18.20 pg/ml相关,但这些关联无统计学意义(P > 0.05)。BMI与AMH/INHB之间的关联在所有协变量中均未显示出显著的交互作用(交互作用P > 0.05),尽管在大多数亚组中存在负相关(P < 0.05)。虽然AMH和INHB均随BMI增加而下降,但在关键阈值30.78 kg/m²(低于该阈值:β = 0.02,P > 0.05;高于该阈值:β = - 0.30,P < 0.05)和33.86 kg/m²(低于该阈值:β = - 1.24,P = 0.05;高于该阈值:β = - 3.22,P < 0.05)处呈现非线性关系。

结论

BMI与成年男性血清AMH和INHB水平存在相对独立的负相关,在肥胖男性中更为明显,且与其他混杂因素无显著交互作用。然而,由于BMI/AMH的效应量较低,在解释其临床意义时需谨慎。尽管我们发现了这些变量之间的非线性关系和关键阈值,但需要更大样本量的进一步研究来证实这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8892/12129801/7b6d3d712e87/fendo-16-1547267-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8892/12129801/57ee0563e3ed/fendo-16-1547267-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8892/12129801/194abeee9b4d/fendo-16-1547267-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8892/12129801/56fbc615e4e6/fendo-16-1547267-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8892/12129801/9e5a39c24de7/fendo-16-1547267-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8892/12129801/7b6d3d712e87/fendo-16-1547267-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8892/12129801/57ee0563e3ed/fendo-16-1547267-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8892/12129801/194abeee9b4d/fendo-16-1547267-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8892/12129801/56fbc615e4e6/fendo-16-1547267-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8892/12129801/9e5a39c24de7/fendo-16-1547267-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8892/12129801/7b6d3d712e87/fendo-16-1547267-g005.jpg

相似文献

1
Body mass index influences Antimüllerian Hormone and inhibin B in adult males.体重指数影响成年男性的抗苗勒管激素和抑制素B。
Front Endocrinol (Lausanne). 2025 May 20;16:1547267. doi: 10.3389/fendo.2025.1547267. eCollection 2025.
2
Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.血清抗苗勒管激素和抑制素B在预测多囊卵巢综合征患者卵巢反应中的临床价值
J Huazhong Univ Sci Technolog Med Sci. 2017 Feb;37(1):70-73. doi: 10.1007/s11596-017-1696-x. Epub 2017 Feb 22.
3
Updated assays for inhibin B and AMH provide evidence for regular episodic secretion of inhibin B but not AMH in the follicular phase of the normal menstrual cycle.更新的抑制素 B 和 AMH 检测方法为正常月经周期滤泡期抑制素 B 而非 AMH 的周期性有规律分泌提供了证据。
Hum Reprod. 2014 Mar;29(3):592-600. doi: 10.1093/humrep/det447. Epub 2013 Dec 18.
4
Elderly men have low levels of anti-Müllerian hormone and inhibin B, but with high interpersonal variation: a cross-sectional study of the sertoli cell hormones in 615 community-dwelling men.老年男性的抗苗勒管激素和抑制素 B 水平较低,但个体间差异较大:615 名社区居住男性的支持细胞激素的横断面研究。
PLoS One. 2013 Aug 5;8(8):e70967. doi: 10.1371/journal.pone.0070967. Print 2013.
5
Urinary phthalate metabolites in relation to serum anti-Müllerian hormone and inhibin B levels among women from a fertility center: a retrospective analysis.生育中心女性尿液邻苯二甲酸代谢物与血清抗苗勒管激素和抑制素 B 水平的关系:一项回顾性分析。
Reprod Health. 2018 Feb 23;15(1):33. doi: 10.1186/s12978-018-0469-8.
6
Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients.化疗前抗苗勒管激素、年龄和身体大小可预测年轻乳腺癌患者卵巢功能恢复的时间。
Cancer. 2014 Dec 1;120(23):3691-8. doi: 10.1002/cncr.28942. Epub 2014 Jul 31.
7
[Orchidopexy increases the levels of serum anti-Müllerian hormone and inhibin B in cryptorchidism patients].[睾丸固定术可提高隐睾症患者血清抗苗勒管激素和抑制素B水平]
Zhonghua Nan Ke Xue. 2017 Aug;23(8):713-716.
8
Association of body mass index with serum anti-Müllerian hormone and inhibin B levels among 8323 women attending a reproductive medical center: a cross-sectional study.在一家生殖医学中心就诊的 8323 名女性中,体质量指数与血清抗苗勒管激素和抑制素 B 水平的相关性:一项横断面研究。
Endocrine. 2022 Jan;75(1):284-292. doi: 10.1007/s12020-021-02839-2. Epub 2021 Aug 7.
9
The dynamic changes of anti-Mullerian hormone and inhibin B during controlled ovarian hyperstimulation in decreased ovarian reserve women and the effect on clinical outcome.卵巢储备功能下降女性在控制性卵巢刺激过程中抗苗勒管激素和抑制素B的动态变化及其对临床结局的影响。
Gynecol Endocrinol. 2015 Jun;31(6):450-3. doi: 10.3109/09513590.2014.998187. Epub 2015 Jan 14.
10
Serum Anti-Müllerian Hormone and Inhibin B as Potential Markers for Progressive Central Precocious Puberty in Girls.血清抗苗勒管激素和抑制素B作为女童进行性中枢性性早熟的潜在标志物
J Pediatr Adolesc Gynecol. 2017 Jun;30(3):362-366. doi: 10.1016/j.jpag.2017.01.010. Epub 2017 Feb 1.

本文引用的文献

1
Serum Concentrations of Inhibin B in Healthy Females and Males Throughout Life.健康女性和男性一生中血清抑制素B的浓度。
J Clin Endocrinol Metab. 2024 Dec 18;110(1):70-77. doi: 10.1210/clinem/dgae439.
2
Obesity and male fertility disorders.肥胖与男性生育功能障碍。
Mol Aspects Med. 2024 Jun;97:101273. doi: 10.1016/j.mam.2024.101273. Epub 2024 Apr 8.
3
The Molecular Basis of Male Infertility in Obesity: A Literature Review.肥胖男性不育的分子基础:文献综述。
Int J Mol Sci. 2023 Dec 22;25(1):179. doi: 10.3390/ijms25010179.
4
AMH Regulation by Steroids in the Mammalian Testis: Underlying Mechanisms and Clinical Implications.甾体激素对哺乳动物睾丸中 AMH 的调节:作用机制及临床意义。
Front Endocrinol (Lausanne). 2022 May 31;13:906381. doi: 10.3389/fendo.2022.906381. eCollection 2022.
5
Inhibin-B and FSH Are Good Indicators of Spermatogenesis but Not the Best Indicators of Fertility.抑制素B和卵泡刺激素是精子发生的良好指标,但并非生育能力的最佳指标。
Life (Basel). 2022 Mar 30;12(4):511. doi: 10.3390/life12040511.
6
Anti-Müllerian hormone concentration is associated with central adiposity and reproductive hormones in expectant fathers.抗缪勒管激素浓度与准父亲的中心性肥胖和生殖激素有关。
Clin Endocrinol (Oxf). 2022 Nov;97(5):634-642. doi: 10.1111/cen.14725. Epub 2022 Mar 28.
7
Genetics of anti-Müllerian hormone and its signaling pathway.抗苗勒管激素及其信号通路的遗传学
Best Pract Res Clin Endocrinol Metab. 2022 Jan;36(1):101634. doi: 10.1016/j.beem.2022.101634. Epub 2022 Feb 25.
8
Anti-mullerian hormone attenuates insulin resistance and systemic inflammation in old obese C57BL/6 male mice.抗苗勒管激素可减轻老年肥胖C57BL/6雄性小鼠的胰岛素抵抗和全身炎症。
J Diabetes Metab Disord. 2021 Nov 3;20(2):1697-1704. doi: 10.1007/s40200-021-00925-w. eCollection 2021 Dec.
9
Clinical Applications of Serum Anti-Müllerian Hormone Measurements in Both Males and Females: An Update.血清抗苗勒管激素检测在男性和女性中的临床应用:最新进展
Innovation (Camb). 2021 Feb 9;2(1):100091. doi: 10.1016/j.xinn.2021.100091. eCollection 2021 Feb 28.
10
Estradiol, obesity and hypogonadism.雌二醇、肥胖和性腺功能减退症。
Physiol Res. 2020 Sep 30;69(Suppl 2):S273-S278. doi: 10.33549/physiolres.934510.